Outcomes of an integrated care pathway for concurrent major depressive and alcohol use disorders: a multisite prospective cohort study.
Andriy V SamokhvalovCharlotte ProbstSaima AwanTony P GeorgeBernard Le FollPeter VooreJürgen RehmPublished in: BMC psychiatry (2018)
The study demonstrated that ICP is a feasible and effective treatment for concurrent AUD and MDD that delivers meaningful clinical improvement in a variety of settings. A randomized controlled study is needed to properly compare the treatment outcomes between ICP model and treatment as usual and to further explore the role of various factors on treatment outcomes.